NYSE: ENOV
Enovis Corporation
Healthcare · Medical - Devices
Market Cap
$1.50B
52w High
$34.28
52w Low
$19.14
P/E
-1.34
Volume
381.62K
Outstanding Shares
57.56M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 12.05% over the last year. Revenue grew 4.89% over the trailing twelve months. Operating margin moved from -34.5% to 4.14%.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently 4.14%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices.
Valuation
Stock splits
Every 3 shares became 1
Profitability & growth
Analyst consensus
10
Buy
3
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q4 FY26 · EPS est $0.77 · Revenue est $558.47M
View